Precision Neuroscience Corp — Form D
Precision Neuroscience Corp of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-19. The offering totals $45.0M, of which $34.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-12-19
- Form: D
- Accession: 0001567619-22-021752
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $34.3M
- Remaining: $10.7M
- Investors: 15
- Date of first sale: 2022-12-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-467851
Issuer
- Name: Precision Neuroscience Corp
- CIK: 0001858288
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 54 W. 21st St., NEW YORK, NY, 10010
- Phone: 646-771-5881
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Eric M Attias | Director | NEW YORK, NY |
| Craig Mermel | Director | NEW YORK, NY |
| Craig Mermel | Executive Officer | NEW YORK, NY |
| Howard M Morgan | Director | NEW YORK, NY |
| MIchael M Kaswan | Executive Officer | NEW YORK, NY |
| Benjamin Rapoport | Director | NEW YORK, NY |
| Benjamin Rapoport | Executive Officer | NEW YORK, NY |
| Ravi Mehta | Director | NEW YORK, NY |
| Jason Chen | Director | New York, NY |
| Michael Mager | Director | NEW YORK, NY |
| Michael Mager | Executive Officer | NEW YORK, NY |
| Mike M Kaswan | Executive Officer | NEW YORK, NY |
Other filings by this issuer (4)
More